Cargando…

Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients

OBJECTIVES: In addition to motor symptoms, bladder dysfunction is a major clinical issue in patients with Parkinson disease (PD). Istradefylline is adenosine A2A receptor antagonist approved for PD patients with wearing-off symptoms. The aim of this study was to determine the long-term effects of is...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitta, Takeya, Yabe, Ichiro, Kanno, Yukiko, Higuchi, Madoka, Ouchi, Mifuka, Togo, Mio, Moriya, Kimihiko, Takahashi, Ikuko, Matsushima, Masaaki, Sasaki, Hidenao, Shinohara, Nobuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965927/
https://www.ncbi.nlm.nih.gov/pubmed/29672326
http://dx.doi.org/10.1097/WNF.0000000000000281